乳腺癌治疗与乳房再造中肩部功能障碍的发生率:单中心研究
单中心回顾性研究纳入773例乳房切除后乳房再造患者,192例(24.8%)出现肩部功能障碍,平均术后244.8天发生、持续293.4天。多因素分析显示既往肩部问题、腋窝淋巴结清扫、淋巴水肿和西班牙裔种族是显著预测因素,年龄和私人保险为保护因素。
要点
- 乳房切除后乳房再造患者肩部功能障碍发生率约24.8%。
- 腋窝淋巴结清扫和淋巴水肿显著增加肩部功能障碍风险。
- 既往肩部问题与西班牙裔种族亦为显著预测因素。
核心结论
- 肩部功能障碍是乳房切除后乳房再造的常见并发症,与既往肩部问题及淋巴结清扫相关,早期识别风险因素有助于靶向干预。
主要发现
- 773例患者中192例(24.8%)报告肩部功能障碍。
- 肩部功能障碍与术前化疗(P=0.004)、放疗(P=0.003)、右侧乳房切除(P=0.001)及肿瘤性乳房切除(P<0.001)相关。
- 腋窝淋巴结清扫(P<0.001)和淋巴水肿(P<0.001)亦与肩部功能障碍相关。
- 肩部功能障碍平均发生于术后244.8天,持续293.4天。
- 多因素分析显示既往肩部问题(OR=2.287,P=0.049)、腋窝淋巴结清扫(OR=2.556,P=0.049)、淋巴水肿(OR=5.677,P=0.003)和西班牙裔种族(OR=9.049,P=0.019)为显著预测因素。
临床怎么用
- 对具有既往肩部问题、需腋窝淋巴结清扫或合并淋巴水肿的患者,应早期评估并考虑针对性干预以减少肩部功能障碍。
局限性
- 单中心回顾性设计可能限制结果的普适性,需前瞻性研究进一步优化预防策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mastectomy and breast reconstruction aim to restore aesthetics and psychological well-being in patients with breast cancer. However, postoperative shoulder pain and stiffness are common, with varying incidence rates across studies. This study assessed the incidence of and risk factors for shoulder morbidity after breast reconstruction. METHODS: A single-institution retrospective review was conducted from January of 2015 through November of 2023. Women who underwent mastectomy followed by reconstruction were included. Data on demographics, surgical details, therapies, and shoulder outcomes were collected. Unpaired t tests, Fisher exact tests, and multivariable logistic regression models were used to identify risk factors for shoulder impairment. RESULTS: Among 773 patients, 192 (24.8%) reported shoulder impairment, associated with neoadjuvant chemotherapy ( P = 0.004), radiation ( P = 0.003), right-sided mastectomies ( P = 0.001), and oncologic mastectomies ( P < 0.001). Axillary lymph node dissection ( P < 0.001) and lymphedema ( P < 0.001) were also linked. Shoulder impairment occurred, on average, 244.8 days after surgery, lasting 293.4 days. Multivariable analysis identified previous shoulder impairment (odds ratio [OR], 2.287; P = 0.049), axillary lymph node dissection (OR, 2.556; P = 0.049), lymphedema (OR, 5.677; P = 0.003), and Hispanic race (OR, 9.049; P = 0.019) as significant predictors. Age and private insurance were protective factors. CONCLUSIONS: Shoulder impairment is a prevalent complication after mastectomy and breast reconstruction, associated with previous shoulder issues and lymph node dissection. Early identification of these risk factors may inform targeted interventions to reduce shoulder morbidity and improve outcomes. Prospective studies are needed to refine prevention strategies for shoulder impairment in breast cancer survivors.
引用
- Foster L, Schuster KA, Escobar-Domingo MJ, et al. Incidence of Shoulder Impairment in Breast Cancer Treatment and Reconstruction: A Single-Institution Study. Plast Reconstr Surg. 2025. PMID: 41453231. doi:10.1097/PRS.0000000000012738
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。